Emerald Advisers, LLC United Therapeutics Corp Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

A detailed history of Emerald Advisers, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Emerald Advisers, LLC holds 1,932 shares of UTHR stock, worth $716,443. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,932
Holding current value
$716,443
% of portfolio
0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
BUY
$311.04 - $363.55 $600,929 - $702,378
1,932 New
1,932 $692,000
Q3 2023

Oct 26, 2023
SELL
$211.82 - $248.24 $978,820 - $1.15 Million
-4,621 Reduced 77.06%
1,376 $310,000
Q2 2023

Jul 25, 2023
SELL
$205.19 - $232.99 $14.8 Million - $16.8 Million
-72,089 Reduced 92.32%
5,997 $1.32 Million
Q1 2023

May 04, 2023
SELL
$212.99 - $276.17 $3.48 Million - $4.52 Million
-16,356 Reduced 17.32%
78,086 $17.5 Million
Q4 2022

Feb 03, 2023
BUY
$205.95 - $280.43 $244,874 - $333,431
1,189 Added 1.28%
94,442 $26.3 Million
Q3 2022

Oct 25, 2022
SELL
$203.3 - $244.17 $13.6 Million - $16.3 Million
-66,840 Reduced 41.75%
93,253 $19.5 Million
Q2 2022

Jul 29, 2022
SELL
$174.81 - $241.14 $7.56 Million - $10.4 Million
-43,266 Reduced 21.28%
160,093 $37.7 Million
Q1 2022

Apr 29, 2022
BUY
$166.16 - $213.96 $2.89 Million - $3.72 Million
17,402 Added 9.36%
203,359 $36.5 Million
Q4 2021

Feb 02, 2022
SELL
$184.32 - $216.08 $709,632 - $831,908
-3,850 Reduced 2.03%
185,957 $40.2 Million
Q3 2021

Oct 28, 2021
BUY
$179.86 - $214.88 $422,131 - $504,323
2,347 Added 1.25%
189,807 $35 Million
Q2 2021

Jul 29, 2021
SELL
$170.47 - $211.93 $1.2 Million - $1.5 Million
-7,068 Reduced 3.63%
187,460 $33.6 Million
Q1 2021

Apr 29, 2021
SELL
$153.94 - $174.85 $2.84 Million - $3.22 Million
-18,426 Reduced 8.65%
194,528 $32.5 Million
Q4 2020

Jan 29, 2021
BUY
$101.87 - $151.79 $2.04 Million - $3.03 Million
19,992 Added 10.36%
212,954 $32.3 Million
Q3 2020

Oct 28, 2020
SELL
$99.9 - $121.13 $519,380 - $629,754
-5,199 Reduced 2.62%
192,962 $19.5 Million
Q2 2020

Jul 28, 2020
BUY
$92.74 - $125.82 $6.32 Million - $8.57 Million
68,104 Added 52.36%
198,161 $24 Million
Q1 2020

Apr 30, 2020
BUY
$79.39 - $115.35 $10.3 Million - $15 Million
130,057 New
130,057 $12.3 Million

Others Institutions Holding UTHR

# of Institutions
679
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email